BACKGROUND The prognostic impact of preoperative gamma-glutamyl transpeptidase to platelet ratio(GPR)levels in patients with solitary hepatitis B virus(HBV)-related hepatocellular carcinoma(HCC)following radical resec...BACKGROUND The prognostic impact of preoperative gamma-glutamyl transpeptidase to platelet ratio(GPR)levels in patients with solitary hepatitis B virus(HBV)-related hepatocellular carcinoma(HCC)following radical resection has not been established.AIM To examine the clinical utility of GPR for prognosis prediction in solitary HBVrelated HCC patients.METHODS A total of 1167 solitary HBV-related HCC patients were retrospectively analyzed.GPR levels were compared with 908 non-HCC individuals.Overall survival(OS)and recurrence-free survival(RFS)were evaluated,and cox proportional hazard model analyses were performed to identify independent risk factors.Differences in characteristics were adjusted by propensity score matching(PSM).Subgroup and stratified survival analyses for HCC risks were performed,and a linear trend of the hazard ratio(HR)according to GPR levels was constructed.RESULTS GPR levels of patients with solitary HBV-related HCC were higher than those with hepatic hemangiomas,chronic hepatitis B and healthy control(adjusted P<0.05).Variable bias was diminished after the PSM balance test.The low GPR group had improved OS(P<0.001)and RFS(P<0.001)in the PSM analysis and when combined with other variables.Multivariate cox analyses suggested that low GPR levels were associated with a better OS(HR=0.5,95%CI:0.36-0.7,P<0.001)and RFS(HR=0.57,95%CI:0.44-0.73,P<0.001).This same trend was confirmed in subgroup analyses.Prognostic nomograms were constructed and the calibration curves showed that GPR had good survival prediction.Moreover,stratified survival analyses found that GPR>0.6 was associated with a worse OS and higher recurrence rate(P for trend<0.001).CONCLUSION Preoperative GPR can serve as a noninvasive indicator to predict the prognosis of patients with solitary HBVrelated HCC.展开更多
Background and Aims:Chronic hepatitis B virus(HBV)infection is a serious health problem worldwide.Evaluating liver injury in patients with hepatitis B e antigen(HBeAg)-negative chronic hepatitis B(CHB)with detectable ...Background and Aims:Chronic hepatitis B virus(HBV)infection is a serious health problem worldwide.Evaluating liver injury in patients with hepatitis B e antigen(HBeAg)-negative chronic hepatitis B(CHB)with detectable HBV DNA and normal alanine aminotransferase(ALT)is crucial to guide their clinical management.We aimed to investigate the stages of liver inflammation and fibrosis as well as the predictive accuracy of gamma-glutamyl transpepti-dase-to-platelet ratio(GPR)in these patients.Methods:A total of 184 treatment-naïve HBeAg-negative CHB pa-tients with detectable HBV DNA and normal ALT were enrolled.The Scheuer scoring system was used to classify liver inflammation and fibrosis.Results:The distribution of patients with different liver inflammation grades were as follows:G0,0(0%);G1,97(52.7%);G2,68(37.0%);G3,12(6.5%);and G4,7(3.8%).The distribution of patients with different liver fibrosis stages were as follows:S0,22(12.0%);S1,72(39.1%);S2,42(22.8%);S3,19(10.3%);and S4,29(15.8%).The areas under the re-ceiver operating characteristic(AUROC)curves of GPR in predicting significant inflammation,severe inflammation,and advanced inflammation were 0.723,0.895,and 0.952,respectively.The accuracy of GPR was significantly superior to that of ALT in predicting liver inflammation.The AUROCs of GPR in predicting significant fibrosis,severe fibrosis,and cirrhosis were 0.691,0.780,and 0.803,respectively.The predictive accuracy of GPR was significantly higher than that of aminotransferase-to-platelet ratio index(APRI)and fibrosis index based on four factors(FIB-4)in identifying advanced fibrosis and cirrhosis,and it was superior to FIB-4 but comparable to APRI in identifying significant fibrosis.Conclusions:Nearly half of the HBeAg-negative CHB patients with detectable HBV DNA and normal ALT levels had significant liver inflammation or fibrosis.GPR can serve as an accurate predictor of liver inflammation and fibrosis in these patients.展开更多
目的比较壳多糖酶3样蛋白1(chitinase-3-like protein 1,CHI3L1)、γ-谷氨酰转肽酶和血小板比值指数(γ-glutamyl transpeptidase platelet ratio index,GPR)对肝纤维化患者的诊断效能。方法回顾性选择2019年1月—2020年6月本院收治的...目的比较壳多糖酶3样蛋白1(chitinase-3-like protein 1,CHI3L1)、γ-谷氨酰转肽酶和血小板比值指数(γ-glutamyl transpeptidase platelet ratio index,GPR)对肝纤维化患者的诊断效能。方法回顾性选择2019年1月—2020年6月本院收治的拟诊为肝纤维化患者524例,所有患者均经肝穿刺活检确诊412例,所有患者均检测CHI3L1和GPR水平,并与肝穿刺活检结果比较。结果不同分期肝纤维化CHI3L1和GPR水平比较,随着肝纤维化严重程度增加而增加(P<0.05)。CHI3L1检查肝纤维化患者与活体穿刺结果准确率为96.84%,Kappa=0.76,提示CHI3L1检查与活体穿刺结果有较高的一致性;GPR检查与活体穿刺准确率为52.91%,Kappa=0.48,提示GPR检查肝纤维化患者与肝活体穿刺结果的一致性一般。CHI3L1诊断肝纤维化的AUC为0.939,灵敏度为89.83%,特异度为77.75%;GPR诊断肝纤维化的AUC为0.829,灵敏度为79.66%,特异度为79.77%。CHI3L1检验肝纤维化的AUC高于GPR检验肝纤维化的AUC。结论CHI3L1较GPR更利于作为肝纤维化的诊断及不同分期肝纤维化的标记物,因其不同分期表达水平不同,其也可作为动态观察肝纤维化进展的检测标记物。展开更多
目的探讨γ-谷氨酰转肽酶和血小板比值指数(γ-glutamyl transpeptidase to platelet ratio index,GPRI)对原发性肝癌经导管动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)术后发生急性肝功能恶化(acute liver function ...目的探讨γ-谷氨酰转肽酶和血小板比值指数(γ-glutamyl transpeptidase to platelet ratio index,GPRI)对原发性肝癌经导管动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)术后发生急性肝功能恶化(acute liver function deterioration,ALFD)的预测作用。方法回顾性分析2015年6月至2019年12月接受TACE碘油栓塞治疗的141例肝癌临床资料,按文中标准分为ALFD组与对照组,对比两组患者的肝生化指标和GPRI,用ROC曲线和分层卡方检验分析GPRI指数对TACE术后ALFD的预测能力。结果ALFD组Child评分、GPRI指数明显高于对照组,差异有统计学意义。Child-Pugh评分、GPRI AUC分别为0.774、0.784,差异无统计学意义,最佳截点值分别为2.02、6。预测TACE术后ALFD的敏感度、特异度、阳性预测值(PPV)、阴性预测值(NPV)和正确率分别为0.735、0.785、0.521、0.903、0.779和0.588、0.888、0.606、0.870、0.808。分层分析显示,GPRI>2.02是ALFD的危险因素。结论GPRI对肝癌TACE术后ALFD风险具有一定预测价值,GPRI≤2.02可以安全接受TACE治疗,有助于筛选术后ALFD风险难以确定的Child-Pugh B级肝癌患者。展开更多
基金Supported by The National Natural Science Foundation of China,No.81560535,No.81802874 and No.81072321The Self-funded Scientific Research Project of Health Commission in Guangxi Zhuang Autonomous Region,China,No.Z20210977.
文摘BACKGROUND The prognostic impact of preoperative gamma-glutamyl transpeptidase to platelet ratio(GPR)levels in patients with solitary hepatitis B virus(HBV)-related hepatocellular carcinoma(HCC)following radical resection has not been established.AIM To examine the clinical utility of GPR for prognosis prediction in solitary HBVrelated HCC patients.METHODS A total of 1167 solitary HBV-related HCC patients were retrospectively analyzed.GPR levels were compared with 908 non-HCC individuals.Overall survival(OS)and recurrence-free survival(RFS)were evaluated,and cox proportional hazard model analyses were performed to identify independent risk factors.Differences in characteristics were adjusted by propensity score matching(PSM).Subgroup and stratified survival analyses for HCC risks were performed,and a linear trend of the hazard ratio(HR)according to GPR levels was constructed.RESULTS GPR levels of patients with solitary HBV-related HCC were higher than those with hepatic hemangiomas,chronic hepatitis B and healthy control(adjusted P<0.05).Variable bias was diminished after the PSM balance test.The low GPR group had improved OS(P<0.001)and RFS(P<0.001)in the PSM analysis and when combined with other variables.Multivariate cox analyses suggested that low GPR levels were associated with a better OS(HR=0.5,95%CI:0.36-0.7,P<0.001)and RFS(HR=0.57,95%CI:0.44-0.73,P<0.001).This same trend was confirmed in subgroup analyses.Prognostic nomograms were constructed and the calibration curves showed that GPR had good survival prediction.Moreover,stratified survival analyses found that GPR>0.6 was associated with a worse OS and higher recurrence rate(P for trend<0.001).CONCLUSION Preoperative GPR can serve as a noninvasive indicator to predict the prognosis of patients with solitary HBVrelated HCC.
基金funded by the National Natural Science Foundation of China(82002133)Jiangsu Provincial Medical Innovation Team(CXTDA2017005)+4 种基金Nanjing Medical Science,Technique Development Foundation(QRX17121)Yangzhou Key R&D Program(Social Development)(YZ2020101)China Postdoctoral Science Foundation for COVID-19(2020T130049ZX)Natural Science Foundation of Jiangsu Province for Young Scholars(BK20200266)Foundation Project of Jiangsu Commission of Health(Q2017003).
文摘Background and Aims:Chronic hepatitis B virus(HBV)infection is a serious health problem worldwide.Evaluating liver injury in patients with hepatitis B e antigen(HBeAg)-negative chronic hepatitis B(CHB)with detectable HBV DNA and normal alanine aminotransferase(ALT)is crucial to guide their clinical management.We aimed to investigate the stages of liver inflammation and fibrosis as well as the predictive accuracy of gamma-glutamyl transpepti-dase-to-platelet ratio(GPR)in these patients.Methods:A total of 184 treatment-naïve HBeAg-negative CHB pa-tients with detectable HBV DNA and normal ALT were enrolled.The Scheuer scoring system was used to classify liver inflammation and fibrosis.Results:The distribution of patients with different liver inflammation grades were as follows:G0,0(0%);G1,97(52.7%);G2,68(37.0%);G3,12(6.5%);and G4,7(3.8%).The distribution of patients with different liver fibrosis stages were as follows:S0,22(12.0%);S1,72(39.1%);S2,42(22.8%);S3,19(10.3%);and S4,29(15.8%).The areas under the re-ceiver operating characteristic(AUROC)curves of GPR in predicting significant inflammation,severe inflammation,and advanced inflammation were 0.723,0.895,and 0.952,respectively.The accuracy of GPR was significantly superior to that of ALT in predicting liver inflammation.The AUROCs of GPR in predicting significant fibrosis,severe fibrosis,and cirrhosis were 0.691,0.780,and 0.803,respectively.The predictive accuracy of GPR was significantly higher than that of aminotransferase-to-platelet ratio index(APRI)and fibrosis index based on four factors(FIB-4)in identifying advanced fibrosis and cirrhosis,and it was superior to FIB-4 but comparable to APRI in identifying significant fibrosis.Conclusions:Nearly half of the HBeAg-negative CHB patients with detectable HBV DNA and normal ALT levels had significant liver inflammation or fibrosis.GPR can serve as an accurate predictor of liver inflammation and fibrosis in these patients.
文摘目的比较壳多糖酶3样蛋白1(chitinase-3-like protein 1,CHI3L1)、γ-谷氨酰转肽酶和血小板比值指数(γ-glutamyl transpeptidase platelet ratio index,GPR)对肝纤维化患者的诊断效能。方法回顾性选择2019年1月—2020年6月本院收治的拟诊为肝纤维化患者524例,所有患者均经肝穿刺活检确诊412例,所有患者均检测CHI3L1和GPR水平,并与肝穿刺活检结果比较。结果不同分期肝纤维化CHI3L1和GPR水平比较,随着肝纤维化严重程度增加而增加(P<0.05)。CHI3L1检查肝纤维化患者与活体穿刺结果准确率为96.84%,Kappa=0.76,提示CHI3L1检查与活体穿刺结果有较高的一致性;GPR检查与活体穿刺准确率为52.91%,Kappa=0.48,提示GPR检查肝纤维化患者与肝活体穿刺结果的一致性一般。CHI3L1诊断肝纤维化的AUC为0.939,灵敏度为89.83%,特异度为77.75%;GPR诊断肝纤维化的AUC为0.829,灵敏度为79.66%,特异度为79.77%。CHI3L1检验肝纤维化的AUC高于GPR检验肝纤维化的AUC。结论CHI3L1较GPR更利于作为肝纤维化的诊断及不同分期肝纤维化的标记物,因其不同分期表达水平不同,其也可作为动态观察肝纤维化进展的检测标记物。
文摘目的探讨γ-谷氨酰转肽酶和血小板比值指数(γ-glutamyl transpeptidase to platelet ratio index,GPRI)对原发性肝癌经导管动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)术后发生急性肝功能恶化(acute liver function deterioration,ALFD)的预测作用。方法回顾性分析2015年6月至2019年12月接受TACE碘油栓塞治疗的141例肝癌临床资料,按文中标准分为ALFD组与对照组,对比两组患者的肝生化指标和GPRI,用ROC曲线和分层卡方检验分析GPRI指数对TACE术后ALFD的预测能力。结果ALFD组Child评分、GPRI指数明显高于对照组,差异有统计学意义。Child-Pugh评分、GPRI AUC分别为0.774、0.784,差异无统计学意义,最佳截点值分别为2.02、6。预测TACE术后ALFD的敏感度、特异度、阳性预测值(PPV)、阴性预测值(NPV)和正确率分别为0.735、0.785、0.521、0.903、0.779和0.588、0.888、0.606、0.870、0.808。分层分析显示,GPRI>2.02是ALFD的危险因素。结论GPRI对肝癌TACE术后ALFD风险具有一定预测价值,GPRI≤2.02可以安全接受TACE治疗,有助于筛选术后ALFD风险难以确定的Child-Pugh B级肝癌患者。
